Product logins

Find logins to all Clarivate products below.


Facial Injectables | Medtech 360 | Market Analysis | Europe | 2017

The European facial injectables market will expand through 2025, fueled by high patient demand, economic recovery, product improvements, and an increasing number of practitioners offering these procedures. Nevertheless, tightening regulations and price competition will limit market growth slightly.

The large number of relatively homogeneous products in the market is forcing companies to innovate and increase their focus on promotions and marketing initiatives.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…